TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO Stock
Certificat
DE000SD53YJ1
| Market Closed - Deutsche Boerse AG 15:42:37 2024-06-28 EDT | ||
| 70.38 EUR | +0.46% |
|
| Current month | +15.72% | ||
| 1 month | +17.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 70.38 | +0.46% |
| 24-06-27 | 70.06 | +0.43% |
| 24-06-26 | 69.76 | +0.35% |
| 24-06-25 | 69.52 | +1.18% |
| 24-06-24 | 68.71 | +0.91% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 03:42 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SD53YJ |
| ISIN | DE000SD53YJ1 |
| Date issued | 2021-05-10 |
| Strike | 158.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.12 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 70.85 € |
|---|---|
| Lowest since issue | 5.16 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Certificates
- Certificat
